ClinicalTrials.gov
public full text
Public Domain
A Study of Lebrikizumab in Adults With Nummular Eczema
The main aim of the study is to evaluate the efficacy, safety, and tolerability of lebrikizumab treatment in adult participants with Nummular Eczema (NE) who are not adequately controlled with Topical corticosteroids (TCS) or when this treatment is not medically advisable.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Use of Eculizumab in HELLP Syndrome#148616
- To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis#908905
- Clinical codelists for: "Atopic eczema in adulthood and mortality: UK population-based cohort study, 1998–2016"#268990
- A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)#991682
- Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis#1010386
Record · ID 968622
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive